טוען...
Structural and Dynamic Elucidation of a Non-acid PPARγ Partial Agonist: SR1988
Targeting peroxisome proliferator-activated receptor γ (PPARγ) by synthetic compounds has been shown to elicit insulin sensitising properties in type 2 diabetics. Treatment with a class of these compounds, the thiazolidinediones (TZDs), has shown adverse side effects such as weight gain, fluid reten...
שמור ב:
| הוצא לאור ב: | Nucl Receptor Res |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6428214/ https://ncbi.nlm.nih.gov/pubmed/30906767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11131/2018/101350 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|